InsiderTrades

Form 4 for SNPS Synopsys

Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0001517737-25-000073 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-09-09 2025-09-05 SNPS Glaser Shelagh CFO S - Sale+OE $609.77 -3,655 15.3K -19% -$2.23M
DM 2025-09-09 2025-09-05 SNPS Glaser Shelagh CFO M - OptEx $349.96 +3,655 17.9K +26% +$1.28M
DM 2025-09-09 2025-09-05 SNPS Glaser Shelagh CFO M - OptEx $0.00 -3,655 13.1K -22% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-05 S D 1,043 $609.77 15,317 D — —
2 Common Common Stock 2025-09-05 M A 1,043 $354.45 16,360 D — —
3 Common Common Stock 2025-09-05 M A 2,612 $348.17 17,929 D — —
4 Common Common Stock 2025-09-05 S D 2,612 $609.77 15,317 D — —
5 Derivative Non-Qualified Stock Option (right to buy) 2025-09-05 M D 1,043 $0.00 6,409 D $354.45 · 2024-02-17 to 2030-02-17 1,043 Common Stock (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
6 Derivative Non-Qualified Stock Option (right to buy) 2025-09-05 M D 2,612 $0.00 13,061 D $348.17 · 2023-12-02 to 2029-12-02 2,612 Common Stock (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.